MEDICAL NEWS TODAY | DAILY NEWS
A drug candidate created with AI reduced biological age markers across 6 proteomic clocks in a phase 2a trial, suggesting that it may help reverse predicted biological aging.
 
MEDICALNEWSTODAY | DAILY NEWS
 
 
AI-designed lung disease drug lowers biological age markers in early trial
 
READ ON
→
Why smokers may have a lower Parkinson's risk: It's not the nicotine
 
READ ON
→
Seed cycling for hormonal balance: Does it work?
 
READ ON
→
 
 
 
 
 
What to know about non-small cell lung cancer (NSCLC)
 
 
 
 
 
 
 
 
 
MNT
 
fb   tw